Literature DB >> 17676708

Discrete-time survival models with long-term survivors.

Xiaobing Zhao1, Xian Zhou.   

Abstract

Discrete-time survival data typically possess three features: discreteness, ties, and concomitant information, which require appropriate discrete-time models to analyze. In this paper, we first review some existing discrete-time survival models and then extend them to discrete-time cure survival models, which account for the presence of long-term survivors (cured individuals). The maximum likelihood estimation as well as approximate partial likelihood approaches are used to estimate the model parameters. Simulation results are shown to support the suitability of such models for discrete-time survival data with long-term survivors. An example of applications on a set of bladder tumor recurrence data is also presented.

Entities:  

Mesh:

Year:  2008        PMID: 17676708     DOI: 10.1002/sim.3018

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  Empirical receiver operating characteristic curve for two-sample comparison with cure fractions.

Authors:  Xiaobing Zhao; Xian Zhou
Journal:  Lifetime Data Anal       Date:  2010-03-11       Impact factor: 1.588

2.  Sample size calculation for the proportional hazards cure model.

Authors:  Songfeng Wang; Jiajia Zhang; Wenbin Lu
Journal:  Stat Med       Date:  2012-07-11       Impact factor: 2.373

3.  Proportional exponentiated link transformed hazards (ELTH) models for discrete time survival data with application.

Authors:  Hee-Koung Joeng; Ming-Hui Chen; Sangwook Kang
Journal:  Lifetime Data Anal       Date:  2015-03-15       Impact factor: 1.588

4.  Cure models to estimate time until hospitalization due to COVID-19: A case study in Galicia (NW Spain).

Authors:  Maria Pedrosa-Laza; Ana López-Cheda; Ricardo Cao
Journal:  Appl Intell (Dordr)       Date:  2021-05-12       Impact factor: 5.086

5.  Assessing robustness of hazard ratio estimates to outcome misclassification in longitudinal panel studies with application to Alzheimer's disease.

Authors:  Le Wang; Rebecca A Hubbard; Rod L Walker; Edward B Lee; Eric B Larson; Paul K Crane
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.